Series S No. S-001 THE WARRANT REPRESENTED BY THIS CERTIFICATE AND THE OTHER SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED...Warrant Agreement • December 2nd, 2003 • Neoprobe Corp • Surgical & medical instruments & apparatus • Delaware
Exhibit 10.1.40 OPTION AGREEMENT THIS AGREEMENT entered into this 1st day of February 2000 between Neoprobe Corporation, a Delaware corporation with principal offices at 425 Metro Place North, Suite 300, Dublin, Ohio 43017-1331 (hereinafter...Option Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
ARTICLE I DEFINITIONSShare Purchase Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances
TERMS:Stockholders Agreement • August 14th, 1998 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
1 - 2 2. The definition of "Section 11(a)(ii) Event" contained in Section 1.(a) of the Agreement is hereby deleted in its entirety and the following language be inserted in lieu thereof:Rights Agreement • April 12th, 1999 • Neoprobe Corp • In vitro & in vivo diagnostic substances
RECITALS:Termination Agreement • November 12th, 1999 • Neoprobe Corp • In vitro & in vivo diagnostic substances
PREAMBLE:Separation Agreement • April 12th, 1999 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
EXHIBIT 10.4 SECURITY AGREEMENT THIS SECURITY AGREEMENT (as amended, supplemented, restated or otherwise modified from time to time, the "SECURITY AGREEMENT"), dated as of December 13, 2004, made by Neoprobe Corporation, a Delaware corporation...Security Agreement • December 16th, 2004 • Neoprobe Corp • Surgical & medical instruments & apparatus • New York
STOCK PURCHASE AGREEMENT BY AND AMONG DAN MANOR, ELI LEVI, RONI BIBI, FIRST ISRATECH FUND LP, FIRST ISRATECH FUND LLC, FIRST ISRATECH FUND NORWAY A.S. GREATWAY COMMERCIAL INC., UZI ZUCKER, CAREMI PARTNERS, EMICAR, LLC, AND MA'ARAGIM ENTERPRISES LTD....Stock Purchase Agreement • January 8th, 2002 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Delaware
Exhibit 10.3 AMENDMENT 2 TO THE RIGHTS AGREEMENT This Amendment 2 ("Amendment") to the Rights Agreement ("Agreement") between Neoprobe Corporation, a Delaware corporation ("Company"), and Continental Stock Transfer & Trust Company ("Rights Agent") is...Rights Agreement • March 31st, 2005 • Neoprobe Corp • Surgical & medical instruments & apparatus
EV PRODUCTSSupply Agreement • June 3rd, 1999 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Pennsylvania
NAVIDEA BIOPHARMACEUTICALS, INC. 8,000,000 Common Stock (par value $.001 per share) Underwriting AgreementUnderwriting Agreement • June 17th, 2019 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Navidea Biopharmaceuticals, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 8,000,000 shares of its common stock, par value $.001 per share (the “Shares”). The 8,000,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,200,000 Shares as provided in Section 2. The additional 1,200,000 Shares that may be sold by the Company pursuant to such option are collectively called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” H.C. Wainwright & Co., LLC (“Wainwright”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares
Change of Annual Control Name Base Salary Severance Severance --------------- ----------- --------- --------- Rodger A. Brown $ 115,000 $ 115,000 $ 230,000 Brent L. Larson $ 135,000 $ 135,000 $ 270,000Employment Agreement • March 30th, 2004 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
EXHIBIT 10.34 THE WARRANTS REPRESENTED BY THIS CERTIFICATE AND THE OTHER SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE...Warrant Agreement • December 2nd, 2003 • Neoprobe Corp • Surgical & medical instruments & apparatus • Delaware
1 Exhibit 10.2.55 AGREEMENT, RELEASE AND WAIVER THIS AGREEMENT, RELEASE AND WAIVER (the "Agreement") is a contract between the undersigned employee ("you") who is being involuntarily and without cause, separated from employment on March 31, 2000 (the...Severance Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT BY AND AMONG NEOPROBE CORPORATION BIOMEDICAL VALUE FUND, L.P. BIOMEDICAL OFFSHORE VALUE FUND, LTD.Securities Purchase Agreement • December 16th, 2004 • Neoprobe Corp • Surgical & medical instruments & apparatus • Delaware
EXHIBIT 10.36 EMPLOYMENT AGREEMENT This Employment Agreement is made and entered into effective as of November 1, 2003 (the "Effective Date"), by and between NEOPROBE CORPORATION, a Delaware Corporation with a place of business at 425 Metro Place...Employment Agreement • May 14th, 2004 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
NAVIDEA BIOPHARMACEUTICALS, INC. Warrant To Purchase Common StockWarrant Agreement • August 2nd, 2022 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
THIS WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (Eastern Time) on _____, 20271 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to Holde
April 2, 2003Security Agreement • April 9th, 2003 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
WARRANT TO PURCHASE COMMON STOCK OF NEOPROBE CORPORATIONWarrant Agreement • April 9th, 2003 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
WARRANT TO PURCHASE COMMON STOCK OF NEOPROBE CORPORATIONWarrant Agreement • March 30th, 2004 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
BIOSONIX LTD.Executive Employment Agreement • March 8th, 2002 • Neoprobe Corp • In vitro & in vivo diagnostic substances
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 4th, 2006 • Neoprobe Corp • Surgical & medical instruments & apparatus • Illinois
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of December 1, 2006, by and between NEOPROBE CORPORATION, a Delaware corporation, (the "Company"), and FUSION CAPITAL FUND II, LLC (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
RECITALSShareholder Agreement • January 8th, 2002 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Delaware
SERIES CC COMMON STOCK PURCHASE WARRANT NEOPROBE CORPORATIONCommon Stock Purchase Warrant • November 12th, 2010 • Neoprobe Corp • Surgical & medical instruments & apparatus
THIS SERIES CC COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the one (1) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Neoprobe Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.1 EMPLOYMENT AGREEMENT This Employment Agreement is made and entered into effective as of January 1, 2005 (the "Effective Date"), by and between NEOPROBE CORPORATION, a Delaware Corporation with a place of business at 425 Metro Place North,...Employment Agreement • January 5th, 2005 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
PREAMBLERestricted Stock Purchase Agreement • March 31st, 1997 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
AMENDMENT NO. 1 TO AMENDED AND RESTATED REVOLVING CREDIT NOTE DATED AS OF DECEMBER 31, 1999Revolving Credit Note • March 30th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
WARRANT AGENCY AGREEMENTWarrant Agency Agreement • August 2nd, 2022 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
WARRANT AGENCY AGREEMENT, dated as of August [ ], 2022 (“Agreement”), by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Warrant Agent”).
RECITALSStock Purchase Agreement • December 2nd, 2003 • Neoprobe Corp • Surgical & medical instruments & apparatus • New York
EXHIBIT 10.4.23 --------------- LOAN AGREEMENT -------------- This agreement is made effective April 16, 1998, between Neoprobe Corporation, a Delaware corporation ("Borrower"), and Bank One, NA, a national banking association ("Lender"). Background...Loan Agreement • August 14th, 1998 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 12th, 2010 • Neoprobe Corp • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 7, 2010, among Neoprobe Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
1 EXHIBIT 10.4.31 ASSET PURCHASE AGREEMENT THIS AGREEMENT is made by and between NEOPROBE EUROPE AKTIEBOLAG, reg. no 556440-1510, a corporation organized and existing under the laws of Sweden, whose registered office is at Solvegatan 41, SE-223 70...Asset Purchase Agreement • November 16th, 1998 • Neoprobe Corp • In vitro & in vivo diagnostic substances
RECITALS:Security Agreement • March 30th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.24 THIS NOTE HAS NOT BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES ADMINISTRATOR OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER REGULATION D PROMULGATED UNDER THE SECURITIES ACT...Note Purchase Agreement • March 30th, 2004 • Neoprobe Corp • Surgical & medical instruments & apparatus • Ohio
